Chemo-treatment with AF(D)NMs significantly inhibited growth of and transcoelomic metastasis of EOC (via reducing MUC16 antigen expression on tumor xenografts) and reduced the production of ascitic fluid, thereby possessing potential for increasing longevity in patients with ovarian carcinoma. This evidence concerns the gene MUC16 and neoplasm.